ArticleProceedings of the National Academy of Sciences of the United States of America2016

ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.

Mark A Gregory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.